Fig. 1: Trial profile.
From: Follow-up of the GHSG HD16 trial of PET-guided treatment in early-stage favorable Hodgkin lymphoma
Abbreviations: CMT combined-modality treatment, PET-2 positron emission tomography after two cycles of chemotherapy, HL Hodgkin lymphoma, ITT intention-to-treat, PP per-protocol. *Deauville score 1–2. **Deauville score ≥3.
